168
Participants
Start Date
April 16, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
Paclitaxel
80 mg/m²
Ramucirumab
8 mg/kg
Zanidatamab
Dose and schedule to be assigned at enrollment
RECRUITING
Arthur J.E. Child Comprehensive Cancer Centre, Calgary
RECRUITING
BCCA - Vancouver, Vancouver
RECRUITING
CancerCare Manitoba, Winnipeg
RECRUITING
QEII Health Sciences Centre, Halifax
RECRUITING
Royal Victoria Regional Health Centre, Barrie
RECRUITING
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
RECRUITING
Kingston Health Sciences Centre, Kingston
RECRUITING
Waterloo Regional Health Network (WRHN), Kitchener
RECRUITING
London Health Sciences Centre Research Inc., London
RECRUITING
Lakeridge Health Oshawa, Oshawa
RECRUITING
Ottawa Hospital Research Institute, Ottawa
RECRUITING
Odette Cancer Centre, Toronto
RECRUITING
St. Michael's Hospital, Toronto
RECRUITING
University Health Network, Toronto
RECRUITING
CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal
RECRUITING
Centre Integre Universitaire De Sante Et De Services, Montreal
RECRUITING
Allan Blair Cancer Centre, Regina
RECRUITING
Saskatoon Cancer Centre, Saskatoon
Collaborators (1)
Jazz Pharmaceuticals
INDUSTRY
Canadian Cancer Trials Group
NETWORK